A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer
Clinical trial NCT04400188 · COMPLETED
Trial details
- NCT number
- NCT04400188
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-11
- Primary completion
- 2022-01-15
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.